Marksans Pharma Ltd (MARKSANS)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Marksans Pharma Ltd (MARKSANS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013623
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Marksans Pharma Ltd (Marksans Pharma) is a pharmaceutical company that develops, manufactures and markets branded formulations and generic products. The company offers contract research and manufacturing services. Its focus therapy segments comprise antibiotics, antidiabetic, anti-inflammatory, cardiovascular, gynaecology and pain management among others. Marksans Pharma’s research and development capabilities include dossier development, process optimization, chemical synthesis, formulation development, analytical development, and conducting stability studies. The company operates sophisticated manufacturing plant in Goa. It markets its products through a network of distributors in the US, the UK, Australia, New Zealand and Canada, among others. Marksans Pharma is headquartered in Mumbai, Maharashtra, India.

Marksans Pharma Ltd (MARKSANS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Marksans Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Marksans Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Marksans Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Marksans Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Marksans Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Marksans Pharma Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Breckenridge Pharma Enters Into Co-Marketing Agreement With Marksans Pharma For Gabapentin Capsules 10
Equity Offering 11
Marksans Pharma Raises USD21 Million in Private Placement of Shares 11
Acquisition 12
Marksans Pharma Acquires Time-Cap Lab 12
Marksans Pharma Ltd – Key Competitors 13
Marksans Pharma Ltd – Key Employees 14
Marksans Pharma Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 17
Financial Announcements 17
May 29, 2017: Marksans Pharma Announces Results for Fourth Quarter and Year Ended march 31,2017 17
Feb 06, 2017: Marksans Pharma Reports Financial Results For Quarter Ended December 31, 2016 19
Nov 12, 2016: Marksans Pharma Announces Q2 results for the Quarter ended September 30, 2016 20
Corporate Communications 21
Mar 21, 2016: Marksans Pharma Announces Dr. Balwant Shankarrao Desai has resigned as COO 21
Legal and Regulatory 22
Oct 09, 2017: Marksans Pharma: Receipt of Establishment Inspection Report (EIR) from the US FDA 22
Feb 20, 2017: Marksans Pharma Announces Inspection of Goa Plant by UK MHRA 23
Mar 17, 2016: Marksans’s Goa plant receives Restricted GMP Certificate from UK MHRA 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Marksans Pharma Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Marksans Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Marksans Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Marksans Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Marksans Pharma Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Marksans Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Breckenridge Pharma Enters Into Co-Marketing Agreement With Marksans Pharma For Gabapentin Capsules 10
Marksans Pharma Raises USD21 Million in Private Placement of Shares 11
Marksans Pharma Acquires Time-Cap Lab 12
Marksans Pharma Ltd, Key Competitors 13
Marksans Pharma Ltd, Key Employees 14
Marksans Pharma Ltd, Other Locations 15
Marksans Pharma Ltd, Subsidiaries 15

★海外企業調査レポート[Marksans Pharma Ltd (MARKSANS)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tenaska Inc:発電所・企業SWOT分析
    Tenaska Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • Brooks Automation Inc (BRKS):企業の財務・戦略的SWOT分析
    Brooks Automation Inc (BRKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • CLP Holdings Ltd (2)-エネルギー分野:企業M&A・提携分析
    Summary CLP Holdings Limited (CLP) is an investor and operator in the energy sector of Asia Pacific region. The company invests in power generation, transmission and distribution, and electricity and gas retail activities. Its portfolio includes equity generating and purchase capacities. CLP’s gener …
  • Southern Co (SO):企業の財務・戦略的SWOT分析
    Southern Co (SO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Abu Dhabi Commercial Bank P.J.S.C.:企業の戦略・SWOT・財務情報
    Abu Dhabi Commercial Bank P.J.S.C. - Strategy, SWOT and Corporate Finance Report Summary Abu Dhabi Commercial Bank P.J.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • MYnd Analytics Inc (MYND):医療機器:M&Aディール及び事業提携情報
    Summary MYnd Analytics Inc (MYnd Analytics), formerly CNS Response Inc, is a predictive analytics company. The company develops a decision support tool that assists physicians in the provision of personalized medication for individual patients suffering from mental health issues. It provides Psychia …
  • Hanger, Inc.-医療機器分野:企業M&A・提携分析
    Summary Hanger, Inc. (Hanger) formerly Hanger Orthopedic Group, Inc., is a health care and medical device company. The company along with its subsidiaries offers orthotic and prosthetic (O&P) patient care, and distributes O&P products and rehabilitative solutions. Hanger is one of the largest owner …
  • Pall Corp-医療機器分野:企業M&A・提携分析
    Summary Pall Corp (Pall), a subsidiary of Danaher Corporation, is a supplier of filtration, separation and purification products and technologies to remove solid, liquid and gaseous contaminants from liquids and gases. Its major products include biochemicals, bioreactors, breathers, canisters, cartr …
  • Vodafone Group Plc (VOD):企業の財務・戦略的SWOT分析
    Vodafone Group Plc (VOD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sumitomo Electric Industries Ltd (5802):電力:M&Aディール及び事業提携情報
    Summary Sumitomo Electric Industries Ltd (Sumitomo) is a manufacturing company that develops, manufactures, and sells various products related to electronics, info communications, automotive, industrial materials, and environment and energy. The company’s product portfolio includes wiring harnesses, …
  • Tp Icap Plc:企業の戦略・SWOT・財務分析
    Tp Icap Plc - Strategy, SWOT and Corporate Finance Report Summary Tp Icap Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Edmond de Rothschild (Suisse) S.A.:企業の戦略・SWOT・財務情報
    Edmond de Rothschild (Suisse) S.A. - Strategy, SWOT and Corporate Finance Report Summary Edmond de Rothschild (Suisse) S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • The Blackstone Group LP:企業のM&A・事業提携・投資動向
    The Blackstone Group LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Blackstone Group LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Grand Gulf Energy Ltd (GGE):企業の財務・戦略的SWOT分析
    Summary Grand Gulf Energy Ltd (GGE), formerly Alto Energy International Ltd, is an oil and gas exploration and production company. It acquires, explores and develops conventional oil and gas assets in the US oil and gas basins. In addition, GGE also holds interests in Napoleonville Salt Dome project …
  • Emisphere Technologies Inc (EMIS):企業の戦略的SWOT分析
    Emisphere Technologies Inc (EMIS) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Marriott Vacations Worldwide Corp:企業の戦略・SWOT・財務分析
    Marriott Vacations Worldwide Corp - Strategy, SWOT and Corporate Finance Report Summary Marriott Vacations Worldwide Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • The Israel Electric Corporation Ltd-エネルギー分野:企業M&A・提携分析
    Summary The Israel Electric Corporation Ltd (IECL), formerly Palestine Electric Corporation Ltd. is an integrated electric utility that carries out the generation, transmission, distribution, sale and supply of electricity. The State of Israel owns around 99.85% of the company. It generates power ma …
  • Guided Therapeutics Inc (GTHP)-医療機器分野:企業M&A・提携分析
    Summary Guided Therapeutics Inc (GTI), formerly SpectRx Inc is a biotechnology company that offers platform technology for the early detection of disease that leads to cancer. The company provides products for the non-invasive cervical cancer detection markets. Its products include luviva advanced c …
  • Banco Bilbao Vizcaya Argentaria Colombia SA:企業の戦略・SWOT・財務分析
    Banco Bilbao Vizcaya Argentaria Colombia SA - Strategy, SWOT and Corporate Finance Report Summary Banco Bilbao Vizcaya Argentaria Colombia SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Seven Generations Energy Ltd (VII):石油・ガス:M&Aディール及び事業提携情報
    Summary Seven Generations Energy Ltd (7G) is an independent oil and gas exploration and development company that acquires, develops and explores natural gas resource plays for the production of natural gas in Canada. The company holds interests in the Alberta Deep Basin located in the south of Grand …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆